Caas Capital Management LP Trillium Therapeutics Inc. Transaction History
Caas Capital Management LP
- $836 Million
- Q3 2024
A detailed history of Caas Capital Management LP transactions in Trillium Therapeutics Inc. stock. As of the latest transaction made, Caas Capital Management LP holds 100,000 shares of TRIL stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$0% of portfolio
0.01%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
About Trillium Therapeutics Inc.
- Ticker TRIL
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,995,000
- Market Cap $1.94B